Lens Epithelial Cells Express CD95 and CD95 Ligand Treatment Induces Cell death and DNA Fragmentation in Vitro

Abstract

Purpose

Despite advances in intraocular lens design and material, posterior capsule opacification remains one of the major problems in modern cataract surgery. Therefore, the use of antiproliferative agents has been advocated. CD95 ligand (CD95L, Fas, Apo-1) is a death ligand that triggers apoptosis in susceptible target cells. Apoptosis allows for the safe disposal of cells without damaging the surrounding tissue. The goal of this study was to characterize and evaluate CD95L-induced cell death in cultured lens epithelial cells (LEC).

Methods

Expression of CD95 in untreated porcine LEC was investigated by flow cyto metry. Cell death after CD95L or CD95 agonistic antibody treatment was assessed by crystal violet assay and DNA fragmentation was measured by comet assay.

Results

The presence of CD95 was observed in LEC. CD95L treatment resulted in a time-and concentration-dependent killing of LEC, which was synergistically enhanced by the addition of cyclohexamide. CD95L treatment induced DNA fragmentation.

Conclusions

The present study confirms the use of apoptosis-inducing CD95L in the inhibition of LEC proliferation. Further studies are needed before clinical application of CD95L to inhibit posterior capsule opacification will be feasible.

Keywords

Lens epithelial cells CD95 ligand Apoptosis

Get full access to this article

View all access options for this article.

References

Nishi

. Preventing posterior capsule opacification by creating a discontinuous sharp bend in the capsule. J Cataract Refract Surg 1999; 25: 521–6.

Kato

Kurosaka

Nagamoto

. Apoptotic cell death in rabbit lens after lens extraction. Invest Ophthalmol Vis Sci 1997; 38: 2322–30.

Walczak

Krammer

P.H.

. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 2000; 256: 58–66.

Rensing-Ehl

Frei

Flury

Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo.

Eur J Immunol 1995; 25: 2253–8.

Nishi

Imanishi

. Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts. Br J Ophthalmol 1992; 76: 338–41.

Weller

Malipiero

Rensing

E.A.

Barr

P.J.

Fontana

. Fas/APO-1 gene transfer for human malignant glioma. Cancer Res 1995; 55: 2936–44.

Hueber

Esser

Heimann

Kociok

Winter

Weller

. The topoisomerase I inhibitors, camptothecin and beta-lapachone, induce apoptosis of human retinal pigment epithelial cells. Exp Eye Res 1998; 67: 525–30.

Gopalakrishna

Khar

. Comet assay to measure DNA damage in apoptotic cells. J Biochem Biophys Methods 1995; 30: 69–73.

Webb

J.L.

. Effects of more than one inhibitor. In: Enzym and metabolic inhibitors, General principles of inhibition. New York: Academic Press, 1963; 487–512.

10.

Schaumberg

D.A.

Dana

M.R.

Christen

W.G.

Glynn

R.J.

. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology 1998; 105: 1213–21.

11.

Apple

D.J.

Solomon

K.D.

Tetz

M.R.

Posterior capsule opacification.

Surv Ophthalmol 1992; 37: 73–116.

12.

Nishi

Fujiwara

Shirasawa

. Effects of diclofenac sodium and indomethacin on proliferation and collagen synthesis of lens epithelial cells in vitro. J Cataract Refract Surg 1995; 21: 461–5.

13.

Power

W.J.

Neylan

Collum

L.M.

. Daunomycin as an inhibitor of human lens epithelial cell proliferation in culture. J Cataract Refract Surg 1994; 20: 287–90.

14.

Hepsen

I.F.

Bayramlar

Gultek

Ozen

Tilgen

Evereklioglu

. Caffeic acid phenethyl ester to inhibit posterior capsule opacification in rabbits. J Cataract Refract Surg 1997; 23: 1572–6.

15.

Legler

U.F.

Apple

D.J.

Assia

E.I.

Bluestein

E.C.

Castaneda

V.E.

Mowbray

S.L.

. Inhibition of posterior capsule opacification: the effect of colchicine in a sustained drug delivery system. J Cataract Refract Surg 1993; 19: 462–70.

16.

Haus

C.M.

Galand

A.L.

. Mitomycin against posterior capsular opacification: an experimental study in rabbits. Br J Ophthalmol 1996; 80: 1087–91.

17.

Sharma

Wang

R.X.

Zhang

L.Y.

Death the Fas way: regulation and pathophysiology of CD95 and its ligand.

Pharmacol Ther 2000; 88: 333–47.

18.

Griffith

T.S.

Brunner

Fletcher

S.M.

Green

D.R.

Ferguson

T.A.

. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189–92.

19.

Sugita

Taguchi

Takase

Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis.

Br J Ophthalmol 2000; 84: 1130–4.

20.

Mochizuki

Sugita

Ishikawa

Watanabe

. Immunoregulation by aqueous humor. Cornea 2000; 19(Suppl): S24–5.

21.

Jordan

J.F.

Kociok

Grisanti

Specific features of apoptosis in human lens epithelial cells induced by mitomycin C in vitro.

Graefes Arch Clin Exp Ophthalmol 2001; 239: 613–8.

22.

Nishi

Wada

Ohmoto

Akura

. Inhibition of lens epithelial cells by Fas-specific antibody activating Fas-Fas ligand system. Curr Eye Res 2001; 23: 192–8.

23.

Weller

Frei

Groscurth

Krammer

P.H.

Yonekawa

Fontana

. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 1994; 94: 954–64.

24.

Esser

Heimann

Abts

Fontana

Weller

. CD95 (Fas/APO-1) antibody-mediated apoptosis of human retinal pigment epithelial cells. Biochem Biophys Res Commun 1995; 213: 1026–34.

25.

Ogasawara

Watanabe-Fukunaga

Adachi

Lethal effect of the anti-Fas antibody in mice.

Nature 1993; 364: 806–9.